Benchmark Gaps Against Venture DNA Criteria
Cross-examine each identified evidence gap against the venture's target criteria, strategic objectives, and investment readiness standards. Evaluate whether the quality, sample size, and recency of current proof satisfy stage-gate requirements.
Completing this action alone establishes an objective benchmark of evidence quality against established standards. It prevents confirmation bias by measuring current proof against rigorous external and internal criteria.
Provide a detailed compliance matrix comparing current evidence against required venture DNA thresholds. Highlight exact delta values between current proof standards and stage-gate expectations.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
What specific thresholds in your venture DNA are violated by the current sample size of your user testing?
- 2
Why do you believe your current qualitative feedback meets the statistical threshold for product-market fit?
- 3
How does your evidence benchmark stand up against the scrutiny of an aggressive lead investor?
- 4
In what ways do your operational assumptions conflict with the financial parameters set in your venture DNA?
- 5
What evidence criteria were intentionally relaxed, and what objective risk does that concession introduce?